A Theory Based Intervention to Enhance Information Exchange during Over-The-Counter Consultations in Community Pharmacy: A Feasibility Study
Abstract
:1. Introduction
- Objective 1:
- Evaluate data collection procedures and outcome measures.
- Objective 2:
- Preliminary exploration of the effect of posters on consumer perceptions about barriers to exchanging information.
- Objective 3:
- Explore pharmacy personnel perceptions about OTC consultation behaviour during the intervention.
- Objective 4:
- Evaluate the acceptability of the intervention study procedures to pharmacy personnel.
- Objective 5:
- Evaluate poster interpretation with consumers.
2. Materials and Methods
2.1. Intervention Strategy
- A pharmacist with information about the qualifications and role of a pharmacist, and
- A consumer with an OTC enquiry engaging in information exchange highlighting the benefit of this behaviour and the reasons it is important.
2.2. Situational Cue Development
2.2.1. Poster Development
2.2.2. Testing of Posters
2.2.3. Badge Development
2.3. Pre-Test of Intervention Study Procedures
- (a)
- Recruitment of pharmacy personnel.
- (b)
- Recruitment of consumer participants.
- (c)
- Logistics of audio-recording OTC consultations including optimal recorder settings.
- (d)
- The number of hours of audio-recording to capture at least 50 OTC consultations.
2.4. Intervention Outcomes
2.4.1. Audio-Recording OTC Consultations
2.4.2. Consumer Questionnaire
2.4.3. Evaluation of Posters
2.5. Pharmacy Personnel Interviews
2.6. Participants
2.7. Fidelity of the Study
2.8. Feasibility Study
2.9. Data Handling and Analysis
3. Results
3.1. Intervention Outcomes
3.1.1. Audio-Recording OTC Consultations
3.1.2. Consumer Questionnaires
3.1.3. Evaluation of Posters
3.2. Pharmacy Personnel Interviews
3.2.1. Pharmacy Personnel Demographics
3.2.2. Pharmacy Personnel Perceptions about Changes during the Intervention
“Sometimes when they [consumers] saw the badges they asked what that was all about and you’d explain.”Pharmacy Assistant 1, (hereafter, Pharmacy Assistant quotes are labelled by the letters ‘PA’ followed by the participant serial number, e.g., ‘1’)
“That something different was going on, people were looking at the poster and then walking in and noticed things were a little bit different.”PA6
“When they [consumers] noticed me wearing the badge [they] would walk straight up to me and say ‘I’d like to speak to a pharmacist.’”PA6
“The badges were a good size. It delineated between who was who. I think it says to the customer: ‘Look, I’m the pharmacy assistant. I’ve got knowledge. I’m not just a check-out chick’.”PA2
“I think because on our badges they’re really small but on yours they were really visible. So I think the pharmacist badges got a lot of notice.”Pharmacist 1 (hereafter, Pharmacist quotes are labelled by the letter ‘P’ followed by the participant serial number, e.g., ‘1’)
“I actually noticed a lot of people looking at the pharmacist badge so when you go out to help someone they know straight away they’re speaking to the pharmacist so it just makes it an easier conversation ‘coz they know what level you’re at.”P1
“You could see them [consumers] reading them [badges] maybe just for the recognition ‘Oh I am talking to the pharmacist’.”P3
3.2.3. Feasibility of the Research Process
How Do You Feel About Having Research and Researchers in the Pharmacy?
“It’s good. I think anything you can do to improve is a good thing.”P5
What Are Your Thoughts on Wearing the Recorder?
“It kind of felt, like, impersonal, a little bit intrusional when we had to wear them when we were having our personal conversations.”(PA6)
Do You Feel It Altered the Way You Work?
“The first couple of times I was probably more conscious about how I spoke then after a while I got used to it [recording device]. It was just there and that was it.”(PA2)
What Worked Well with the Research Process? Did You Encounter any Problems with the Research Process?
“The posters were a little big for our pharmacy because we’re so crowded. But that’s just because we are small. I think if they’re [the posters] too small people wouldn’t notice them so there needs to be a balance.”(P2)
What Would You Recommend to Improve the Process?
“I think the only thing I would say is right at the start I didn’t feel I knew anything. It would probably be good to have known what was being done at the shop. It’s hard to get fully involved if you don’t really know what things are up, is it to do with me or not? Am I a member of this or I am not?”(PA5)
4. Discussion
4.1. Objective 1: Evaluate Data Collection Procedures and Outcome Measures
4.2. Objective 2: Preliminary Exploration of the Effect of Posters on Consumer Perceptions about Barriers to Exchanging Information
4.3. Objective 5: Evaluate Poster Interpretation with Consumers (secondary objective)
4.4. Objective 3: Explore Pharmacy Personnel Perceptions about OTC Consultation Behaviour during the Intervention
4.5. Objective 4: Evaluate the Acceptability of the Intervention Study Procedures to Pharmacy Personnel
4.6. Strengths and Limitations
5. Conclusions
Supplementary Materials
Author Contributions
Funding
Acknowledgments
Conflicts of Interest
References
- Hibbert, D.; Bissell, P.; Ward, P.R. Consumerism and professional work in the community pharmacy. Sociol. Health Illn. 2002, 24, 46–65. [Google Scholar] [CrossRef]
- Hughes, C.M.; McElnay, J.C.; Fleming, G.F. Benefits and risks of self medication. Drug. Saf. 2001, 24, 1027–1037. [Google Scholar] [CrossRef] [PubMed]
- Bennadi, D. Self–medication: A current challenge. J. Basic. Clin. Pharm. 2014, 5, 19–23. [Google Scholar] [CrossRef] [PubMed]
- Blenkinsopp, A.; Bradley, C. Over the Counter Drugs: Patients, society, and the increase in self medication. BMJ 1996, 312, 629–632. [Google Scholar] [CrossRef] [PubMed]
- Cohen, J.P.; Paquett, C.; Cairns, C.P. Switching prescription drugs to over the counter. BMJ 2005, 330, 39–41. [Google Scholar] [CrossRef] [PubMed]
- Therapeutic Goods Administration. Reasons for Scheduling Delegate’s Final Decisions. June 2017. Available online: https://www.tga.gov.au/scheduling-decision-final/scheduling-delegates-final-decisions-june-2017 (accessed on 29 August 2017).
- Association of the European Self–Medication Industry. Switch from Prescription to OTC. Available online: http://www.aesgp.eu/facts-figures/otc-ingredients/#undefined (accessed on 24 October 2017).
- US Food and Drug Administration. Over-the–Counter (OTC) Drug Product Review Process. Available online: https://www.fda.gov/Drugs/DevelopmentApprovalProcess/SmallBusinessAssistance/ucm052786.htm (accessed on 23 October 2017).
- Watson, M.C.; Hart, J.; Johnston, M.; Bond, C.M. Exploring the supply of non-prescription medicines from community pharmacies in Scotland. Pharm. World Sci. 2008, 30, 526–535. [Google Scholar] [CrossRef]
- Dwamena, F.; Holmes–Rovner, M.; Gaulden, C.M.; Jorgenson, S.; Sadigh, G.; Sikorskii, A.; Lewin, S.; Smith, R.C.; Coffey, J.; Olomu, A. Interventions for providers to promote a patient-centred approach in clinical consultations. Cochrane Database Syst. Rev. 2012, 12, CD003267. [Google Scholar] [CrossRef]
- Berger, K.; Eickhoff, C.; Schulz, M. Counselling quality in community pharmacies: Implementation of the pseudo customer methodology in Germany. J. Clin. Pharm. Ther. 2005, 30, 45–57. [Google Scholar] [CrossRef]
- Brata, C.; Gudka, S.; Schneider, C.R.; Everett, A.; Fisher, C.; Clifford, R.M. A review of the information–gathering process for the provision of medicines for self–medication via community pharmacies in developing countries. Res. Social Adm. Pharm. 2013, 9, 370–383. [Google Scholar] [CrossRef]
- Chee, G.; Borowitz, M.; Barraclough, A. Private Sector Health Care in Indonesia; Health Systems 20/20 Project; Abt Associates Inc.: Bethesda, MD, USA, 2009. [Google Scholar]
- Alhomoud, F.; Aljamea, Z.; Almahasnah, R.; Alkhalifah, K.; Basalelah, L.; Alhomoud, F.K. Self–medication and self–prescription with antibiotics in the Middle East–do they really happen? A systematic review of the prevalence, possible reasons, and outcomes. Int. J. Infect. Dis. 2017, 57, 3–12. [Google Scholar] [CrossRef]
- Khalifeh, M.M.; Moore, N.D.; Salameh, P.R. Self-medication misuse in the Middle East: A systematic literature review. Pharmacol. Res. Perspect. 2017, 5, e00323. [Google Scholar] [CrossRef] [PubMed]
- U.K Government. Medicines Act 1968. Available online: http://www.legislation.gov.uk/ukpga/1968/67/introduction (accessed on 23 October 2017).
- Government of Western Australia. Medicines and Poisons Act 2014. Available online: https://www.legislation.wa.gov.au/legislation/statutes.nsf/law_a147008.html (accessed on 23 October 2017).
- Therapeutic Goods Administration. Poisons standard June 2017. Australian Government Department of Health: Australian Capital Territory 2017. Available online: https://www.legislation.gov.au/Details/F2017L00605/Download (accessed on 18 September 2017).
- Government of Western Australia. Pharmacy Regulations 2010. Available online: https://www.slp.wa.gov.au/legislation/statutes.nsf/main_mrtitle_12114_homepage.html (accessed on 18 April 2016).
- National Association of Pharmacy Regulatory Authorities. NDS Process and Scheduling Factors. Available online: https://napra.ca/nds-process-and-scheduling-factors (accessed on 13 May 2019).
- New Zealand Government. Classification of Medicines. Available online: https://www.medsafe.govt.nz/profs/class/clascon.asp (accessed on 20 May 2019).
- US Food and Drug Administration. OTC (Nonprescription) Drugs. Available online: https://www.fda.gov/Drugs/DevelopmentApprovalProcess/HowDrugsareDevelopedandApproved/ucm209647.htm (accessed on 23 October 2017).
- US Food and Drug Administration. Prescription Drugs and OTC Drugs: Questions and Answers. Available online: https://www.fda.gov/drugs/questions-answers/prescription-drugs-and-over-counter-otc-drugs-questions-and-answers (accessed on 08 May 2019).
- Association of the European Self–Medication Industry. Available online: http://www.aesgp.eu/about-us/who-we-are/ (accessed on 13 May 2019).
- Watson, M.; Bond, C.; Grimshaw, J.; Johnston, M. Factors predicting the guideline compliant supply (or non-supply) of non–prescription medicines in the community pharmacy setting. Qual. Saf. Health Care 2006, 15, 53–57. [Google Scholar] [CrossRef] [PubMed]
- Watson, M.C.; Bond, C.M.; Johnston, M.; Mearns, K. Using human error theory to explore the supply of nonprescription medicines from community pharmacies. Qual. Saf. Health Care 2006, 15, 244–250. [Google Scholar] [CrossRef] [PubMed]
- Schneider, C.R.; Everett, A.W.; Geelhoed, E.; Kendall, P.A.; Clifford, R.M. Measuring the assessment and counselling provided with the supply of non-prescription asthma reliever medication: A simulated patient study. Ann. Pharmacother. 2009, 43, 1512–1518. [Google Scholar] [CrossRef] [PubMed]
- Benrimoj, S.I.; Werner, J.B.; Raffaele, C.; Roberts, A.S.; Costa, F.A. Monitoring quality standards in the provision of non-prescription medicines from Australian Community Pharmacies: Results of a national programme. Qual. Saf. Health Care 2007, 16, 354–358. [Google Scholar] [CrossRef] [PubMed]
- Seubert, L.J.; Whitelaw, K.; Boeni, F.; Hattingh, L.; Watson, M.C.; Clifford, R.M. Barriers and facilitators for information exchange during over–the–counter consultations in community pharmacy: A focus group study. Pharmacy 2017, 5, 65. [Google Scholar] [CrossRef] [PubMed]
- Medical Research Council. Developing and Evaluating Complex Interventions: New Guidance. Available online: https://www.mrc.ac.uk/documents/pdf/complex-interventions-guidance (accessed on 29 August 2017).
- Rutter, P.M.; Horsley, E.; Brown, D.T. Evaluation of community pharmacists’ recommendations to standardized patient scenarios. Ann. Pharmacother. 2004, 38, 1080–1085. [Google Scholar] [CrossRef] [PubMed]
- Watson, M.C.; Cleland, J.A.; Bond, C.M. Simulated patient visits with immediate feedback to improve the supply of over-the–counter medicines: A feasibility study. Fam. Pract. 2009, 26, 532–542. [Google Scholar] [CrossRef] [PubMed]
- Michie, S.; Atkins, L.; West, R. The Behaviour Change Wheel. A Guide to Designing Interventions, 1st ed.; Silverback Publishing: Great Britain, UK, 2014; ISBN 9781291846058. [Google Scholar]
- Atkins, L.; Francis, J.; Islam, R.; O’Connor, D.; Patey, A.; Ivers, N.; Foy, R.; Duncan, E.M.; Colquhoun, H.; Grimshaw, J.M.; et al. A guide to using the Theoretical Domains Framework of behaviour change to investigate implementation problems. Implement. Sci. 2017, 12, 77. [Google Scholar] [CrossRef]
- Michie, S.; Johnston, M. Behavior change techniques. In Encyclopedia of Behavioral Medicine; Gellman, M.D., Turner, J.R., Eds.; Springer: New York, NY, USA, 2013; pp. 182–187. ISBN 978-1-4419-1005-9. [Google Scholar]
- Seubert, L.J.; Whitelaw, K.; Hattingh, L.; Watson, M.C.; Clifford, R.M. Interventions to enhance effective communication during over-the–counter consultations in the community pharmacy setting: A systematic review. Res. Social Adm. Pharm. 2018, 14, 979–988. [Google Scholar] [CrossRef]
- Seubert, L.J.; Whitelaw, K.; Hattingh, H.L.; Watson, M.C.; Clifford, R.M. Development of a theory–based intervention to enhance information exchange during Over-The-Counter consultations in community pharmacy. Pharmacy 2018, 6, 117. [Google Scholar] [CrossRef] [PubMed]
- Pharmacy Board of Australia. Guidelines on Practice–Specific Issues. Available online: https://www.pharmacyboard.gov.au/Codes-Guidelines.aspx (accessed on 7 May 2019).
- Western Australian Government. Pharmacy Act 2010. Available online: https://www.slp.wa.gov.au/Index.html (accessed on 22 May 2019).
- Michie, S.; Johnston, M.; Abraham, C.; Lawton, R.; Parker, D.; Walker, A. Making psychological theory useful for implementing evidence based practice: A consensus approach. Qual. Saf. Health Care 2005, 14, 26–33. [Google Scholar] [CrossRef] [PubMed]
- Michie, S.; Van Stralen, M.; West, R. The behaviour change wheel: A new method for characterising and designing behaviour change interventions. Implement. Sci. 2011, 6, 42. [Google Scholar] [CrossRef] [PubMed]
- West, R. Theory of Addiction; Blackwell Publishing: Oxford, UK, 2005; p. 121. [Google Scholar]
- Steg, L.; Van Den Berg, A.E.; De Groot, J.I.M. Environmental Psychology an Introduction; Wiley–Blackwell: Chichester, UK, 2013; ISBN 978-1-119-94219-1. [Google Scholar]
- Bowen, D.J.; Kreuter, M.; Spring, B.; Cofta–Woerpel, L.; Linnan, L.; Weiner, D.; Bakken, S.; Kaplan, C.P.; Squiers, L.; Fabrizio, C.; et al. How we design feasibility studies. Am. J. Prev. Med. 2009, 36, 452–457. [Google Scholar] [CrossRef] [PubMed]
- Orsmond, G.I.; Cohn, E.S. The distinctive features of a feasibility study: Objectives and guiding questions. OTJR (Thorofare N J) 2015, 35, 169–177. [Google Scholar] [CrossRef] [PubMed]
- Antill, J.M.; Woodhead, R.W. Critical Path Methods in Construction Practice; John Wiley & Sons: New York, NY, USA, 1990; ISBN 10 0471620572. [Google Scholar]
- Wujec, T. TED: Got a Wicked Problem? First, Tell Me How You Make Toast. Available online: https://www.youtube.com/watch?v=_vS_b7cJn2A (accessed on 22 May 2019).
- Huijg, J.M.; Gebhardt, W.A.; Crone, M.R.; Dusseldorp, E.; Presseau, J. Discriminant content validity of a theoretical domains framework questionnaire for use in implementation research. Implement. Sci. 2014, 9, 11. [Google Scholar] [CrossRef] [PubMed]
- Commonwealth of Australia. 2033.0.55.001–Census of Population and Housing: Socio–Economic Indexes for Areas (SEIFA), Australia, 2016. Available online: https://www.abs.gov.au/ausstats/[email protected]/Lookup/by%20Subject/2033.0.55.001~2016~Main%20Features~FAQs%20-%20SEIFA%202016~4 (accessed on 24 February 2019).
- Papies, E.K. Situating interventions to bridge the intention–behaviour gap: A framework for recruiting nonconscious processes for behaviour change. Soc. Personal. Psychol. Compass 2017, 11, e12323. [Google Scholar] [CrossRef]
- Commonwealth of Australia. QuickStats 2016 Census. Available online: https://www.abs.gov.au/websitedbs/D3310114.nsf/Home/2016%20QuickStats (accessed on 16 May 2019).
- Shah, B.; Chewning, B. Conceptualizing and measuring pharmacist patient communication: A review of published studies. Res. Social Adm. Pharm. 2006, 2, 153–185. [Google Scholar] [CrossRef]
- Golafshani, N. Understanding reliability and validity in qualitative research. Qual. Rep. 2003, 8, 597–606. [Google Scholar]
- McMillan, S.S.; Kelly, F.; Sav, A.; King, M.A.; Whitty, J.A.; Wheeler, A.J. Consumer and carer views of Australian community pharmacy practice: Awareness, experiences and expectations. J. Pharm. Health Serv. Res. 2014, 5, 29–36. [Google Scholar] [CrossRef]
- Malson, G. Making Your Pharmacy’s Sales Space as Profitable as Possible. Available online: https://www.pharmaceutical-journal.com/opinion/comment/making-your-pharmacys-sales-space-as-profitable-as-possible/10040907.article?firstPass=false (accessed on 03 April 2019).
Week 1 |
|
Week 2 |
|
Week 3 |
|
Week 4 |
|
Following four weeks |
|
ProfRole Poster# | InfoExchange Poster* | |
---|---|---|
Participant, n | ||
Pharmacy 1 | 18 | 19 |
Pharmacy 2 | 19 | 19 |
TOTAL | 37 | 38 |
Female, n (%) | 27 (73) | 28 (74) |
Median age, (IQR) years | 62 (44–71) | 61 (48–76) |
Marital status, n (%) | ||
Single | 10 (27) | 11 (29) |
Married | 18 (49) | 20 (53) |
Other | 9 (24) | 7 (18) |
Highest education, n (%) | ||
High school | 10 (27) | 11 (29) |
Technical or vocational training | 6 (16) | 3 (8) |
University | 18 (49) | 19 (50) |
Other | 3 (8) | 5 (13) |
Language spoken at home, n (%) | ||
English | 37 (100) | 38 (100) |
Usual pharmacy, n (%) | ||
This pharmacy | 22 (59) | 28 (74) |
Another pharmacy | 7 (19) | 4 (11) |
I don’t have one | 8 (22) | 6 (16) |
ProfRole Poster (n = 37) | InfoExchange Poster (n = 38) | ||||||
---|---|---|---|---|---|---|---|
Mean (SD) | Mean Change | Mean (SD) | Mean Change | ||||
TDF * Domain | Question/Statement ^ | Before | After | Before | After | ||
Knowledge | 1. I know that pharmacists are qualified to assist me with my enquiry. | 6.46 (0.84) | 6.54 (0.56) | 0.08 | 6.55 (0.72) | 6.53 (0.65) | –0.02 |
2. I know what the pharmacist’s role and responsibilities are. | 5.76 (1.46) | 5.89 (1.56) | 0.13 | 6.26 (0.98) | 6.24 (1.00) | –0.02 | |
3. I know that giving information to the pharmacist about my health will benefit me. | 6.19 (0.97) | 6.19 (1.31) | 0 | 6.58 (0.83) | 6.58 (0.76) | 0 | |
Environ-mental Context | 4. I can tell who is a pharmacist and who is a pharmacy assistant. | 5.03 (1.82) | 5.16 (1.94) | 0.13 | 5.53 (1.64) | 5.97 (1.42) | 0.44 |
Social and Professional Role and Identity | 5. It is a pharmacist’s job and responsibility to ask me questions about my health. | 5.68 (1.72) | 6.27 (1.04) | 0.59 | 5.66 (1.63) | 6.18 (1.14) | 0.52 |
6. I trust the pharmacist, as a health professional, to discuss what is best for my enquiry. | 6.24 (1.01) | 6.41 (0.80) | 0.17 | 6.53 (0.69) | 6.66 (0.48) | 0.13 | |
7. It is the duty of the pharmacist, as a health processional, to make sure the medicine they recommend/supply is appropriate for me. | 6.19 (1.52) | 6.38 (1.01) | 0.19 | 6.50 (0.65) | 6.53 (0.76) | 0.03 | |
Belief about Capability | 8. I am confident that if I want a specific medicine I can provide information about my health with the pharmacist. | 6.17 (1.08) | 6.33 (0.99) | 0.16 | 6.54 (0.65) | 6.59 (0.60) | 0.05 |
9. I am confident that I can decide if an OTC medicine is appropriate for my condition without help. | 4.38 (1.78) | 4.43 (2.02) | 0.05 | 4.50 (1.66) | 4.19 (1.97) | –0.31 | |
10. Providing information about my health is (difficult-easy) # | 6.08 (0.89) | 6.22 (0.95) | 0.14 | 6.50 (0.86) | 6.34 (0.91) | –0.16 | |
Belief about Consequences | 11. When I provide information about my health, the pharmacist will make sure the medicine is safe and appropriate for me. | 6.20 (1.23) | 6.23 (1.11) | 0.03 | 6.53 (0.60) | 6.50 (0.56) | –0.03 |
12. When I provide information about my health, the pharmacist will keep it confidential/private. | 6.62 (0.55) | 6.70 (0.57) | 0.08 | 6.44 (0.97) | 6.56 (0.94) | 0.12 | |
13. When I buy a medicine OTC, I do not need advice as OTC medicines are safe. | 3.70 (2.12) | 3.89 (2.07) | 0.19 | 3.59 (1.91) | 3.68 (2.00) | 0.09 | |
Intentions | 14. I will definitely provide health information to the pharmacist when purchasing a product/medicine (e.g., ibuprofen, Nurofen®). | 5.11 (1.98) | 5.32 (1.75) | 0.21 | 5.66 (1.85) | 5.95 (1.47) | 0.29 |
15. I intend to provide health information to the pharmacist when I need help with a symptom (e.g., a headache). | 5.78 (1.69) | 5.86 (1.55) | 0.08 | 6.21 (1.30) | 6.47 (0.69) | 0.26 | |
16. How strong is your intention to provide health information to the pharmacist when purchasing a medicine OTC? (not at all strong—very strong) ^^ | 5.47 (1.54) | 5.61 (1.59) | 0.14 | 6.00 (1.19) | 6.13 (1.12) | 0.13 |
Pharmacy 1 (n = 7) | Pharmacy 2 (n = 5) | Total (n = 12) | ||||
---|---|---|---|---|---|---|
Position, n | Pharmacist, 3 | Pharmacy assistant, 4 | Pharmacist, 3 | Pharmacy assistant, 2 | Pharmacy personnel, 12 | |
Age, median (IQR) years | 51.0 (40–56) | 39.5 (33–42) | 52.0 (40–55) | 25.5 (23–28) | 39.5 (29–51) | |
Gender, n | Female | 3 | 4 | 2 | 2 | 11 |
Employment status, n | Full time | 1 | 1 | 2 | 1* | 5 |
Part-time | 2 | 2 | 1 | 0 | 5 | |
Casual | 0 | 1 | 0 | 0 | 1 | |
Pharmacy experience, median (IQR) years | 27.0 (18–34) | 11.3 (9–14) | 31.0 (20–37) | 9.3 (6–13) | 14.0 (8–28) |
© 2019 by the authors. Licensee MDPI, Basel, Switzerland. This article is an open access article distributed under the terms and conditions of the Creative Commons Attribution (CC BY) license (http://creativecommons.org/licenses/by/4.0/).
Share and Cite
Seubert, L.J.; Kerry, W.; Laetitia, H.; Watson, M.C.; Clifford, R.M. A Theory Based Intervention to Enhance Information Exchange during Over-The-Counter Consultations in Community Pharmacy: A Feasibility Study. Pharmacy 2019, 7, 73. https://doi.org/10.3390/pharmacy7020073
Seubert LJ, Kerry W, Laetitia H, Watson MC, Clifford RM. A Theory Based Intervention to Enhance Information Exchange during Over-The-Counter Consultations in Community Pharmacy: A Feasibility Study. Pharmacy. 2019; 7(2):73. https://doi.org/10.3390/pharmacy7020073
Chicago/Turabian StyleSeubert, Liza J., Whitelaw Kerry, Hattingh Laetitia, Margaret C. Watson, and Rhonda M. Clifford. 2019. "A Theory Based Intervention to Enhance Information Exchange during Over-The-Counter Consultations in Community Pharmacy: A Feasibility Study" Pharmacy 7, no. 2: 73. https://doi.org/10.3390/pharmacy7020073
APA StyleSeubert, L. J., Kerry, W., Laetitia, H., Watson, M. C., & Clifford, R. M. (2019). A Theory Based Intervention to Enhance Information Exchange during Over-The-Counter Consultations in Community Pharmacy: A Feasibility Study. Pharmacy, 7(2), 73. https://doi.org/10.3390/pharmacy7020073